Brief: Anixa Biosciences And Moffitt Cancer Center Receive Additional Information Request From Us FDA For Car-T IND Application
20/05/2021 14:18
May 20 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES AND MOFFITT CANCER CENTER RECEIVE
ADDITIONAL
INFORMATION REQUEST FROM US FDA FOR CAR-T IND APPLICATION
* ANIXA BIOSCIENCES INC - CO AND MOFFITT FEEL THAT REQUESTED
INFORMATION CAN BE ASSEMBLED AND PROVIDED TO FDA WITHIN ABOUT 30
DAYS
Source text for Eikon: ID:nPn6HPkbpa
Further company coverage: ANIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine